Phase 2 Acute Myeloid Leukemia, Adult Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia
Acute Myeloid Leukemia, AdultNewly Diagnosed
The First Affiliated Hospital of Soochow University172 enrolled1 locationNCT06532552
Recruiting
Phase 1Phase 2
A Study to Investigate Treatment of HU and VPA, or 6-MP and VPA in Unfit AML/HR-MDS Patients
Acute Myeloid Leukemia, AdultMyelodysplastic Syndromes, Adult
Haukeland University Hospital48 enrolled1 locationNCT06199557
Recruiting
Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
Acute Myeloid Leukemia, AdultAcute Myeloid Leukemia RecurrentAcute Myeloid Leukemia, Relapsed, Adult
University of Maryland, Baltimore39 enrolled1 locationNCT04050280
Recruiting
Phase 1Phase 2
A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML
Acute Myeloid Leukemia, Adult
Sunshine Lake Pharma Co., Ltd.133 enrolled1 locationNCT05133882
Recruiting
Phase 1Phase 2
First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients
Myelodysplastic SyndromesAcute Myeloid Leukemia, Adult
Advanced BioDesign36 enrolled3 locationsNCT05601726